Acupuncture for Heel Pain Syndrome: A Multicenter Randomized Controlled Trial
Clinical Research on Acupuncture at the Heel Pain Point for the Treatment of Heel Pain Syndrome
1 other identifier
interventional
150
1 country
1
Brief Summary
The main goal of this study is to determine if a specific acupuncture technique-targeting a "heel pain point" located on the hand-is an effective and safe way to treat heel pain. Specifically, the researchers want to: Measure Pain Relief: Evaluate how effectively the treatment reduces pain levels. Check Physical Function: Determine if the treatment helps patients walk and move more comfortably. Ensure Safety: Track any side effects or adverse reactions to confirm the treatment is safe for patients. Target Population The study is looking for participants who meet the following criteria: Age: Adults between 40 and 70 years old. Diagnosis: Individuals diagnosed with heel pain (plantar fasciitis). Duration: People who have had the pain for less than two months and have not recently received other related treatments. Typical Symptoms: Individuals who experience significant pain during their first few steps in the morning or after sitting for a long time. Exclusions: The study excludes people with recent foot injuries, gout, or serious underlying health conditions such as severe diabetes or heart disease. Primary Research Endpoint The "Primary Endpoint" is the specific result the researchers use to decide if the treatment was successful: The 50% Reduction Goal: The study measures the "response rate," which is the percentage of patients whose pain score decreases by at least 50% compared to their starting pain level. Evaluation Timing: This success measure is evaluated after the patient completes one full course of treatment, which consists of 10 sessions given over approximately 20 days.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 13, 2026
CompletedFirst Posted
Study publicly available on registry
May 26, 2026
CompletedStudy Start
First participant enrolled
September 1, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
October 30, 2027
Study Completion
Last participant's last visit for all outcomes
October 30, 2027
May 26, 2026
May 1, 2026
1.2 years
May 13, 2026
May 19, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
The response rate after one course of acupuncture intervention (defined as the proportion of subjects achieving a ≥50% reduction in VAS score from baseline)
VAS Score: A 10-cm visual analog scale where 0 represents no pain and 10 represents severe pain (1-3: mild; 4-6: moderate; 7-10: severe).
20 days
Secondary Outcomes (3)
Pain response/remission rate
These will be recorded and evaluated at baseline, upon completion of 1 treatment course, and at 2- and 6-months post-treatment
Functional improvement(Assessed via the Maryland Foot Score.)
These will be recorded and evaluated at baseline, upon completion of 1 treatment course, and at 2- and 6-months post-treatment
Satisfaction:Patient Satisfaction: Statistical proportion of satisfaction calculated as [(Satisfied + Basically Satisfied) / Total Patients] $\times$ 100%.
These will be recorded and evaluated at baseline, upon completion of 1 treatment course, and at 2- and 6-months post-treatment
Study Arms (3)
Acupuncture Group
EXPERIMENTALAcupoint Selection: Contralateral point selection (i.e., the left heel pain point is selected for right heel pain, and vice versa). Heel Pain Point: Located on the palm, 0.8 cun distal to the Daling acupoint (PC7, located on the anterior aspect of the wrist, in the depression of the distal wrist crease, between the tendons of palmaris longus and flexor carpi radialis), toward the thenar eminence. Primary Needles: Hwato brand (0.25 × 40 mm, Suzhou, China). Primary Patch: Spunlace non-woven hollow patch (with cotton) (5 × 5 cm, ring diameter 2.3 cm, cotton diameter 1.5 cm, Yingrui Pharmaceuticals).
Manual Therapy Group
ACTIVE COMPARATORThe patient is positioned supine with the affected lower limb completely relaxed. (1) Kneading and pressing techniques are applied to the affected area using the thumb, with intensity tailored to patient tolerance; focus is placed on localized cord-like structures or fibrous nodules for 5-10 min per session. (2) Horizontal Stretching: With the patient supine and the lower limb extended, the practitioner stabilizes the heel with one hand and pushes the forefoot with the base of the other palm, maximally dorsiflexing the ankle until tension is felt in the Achilles tendon and triceps surae. This stretch is performed 5-10 times for 30 seconds each. (3) Straight-Leg Raise Stretching: The practitioner elevates the affected limb while maintaining knee extension. With the left hand on the heel and the right hand gripping the forefoot, the practitioner leans backward to dorsiflex the ankle until gastrocnemius tension is felt. (4) Ankle Rotation: Building upon step (3), the right han
Sham Acupuncture Control Group
SHAM COMPARATORAcupoint Selection: Contralateral point selection (i.e., the left heel pain point is selected for right heel pain, and vice versa). Heel Pain Point: Located on the palm, 0.8 cun distal to the Daling acupoint (PC7, located on the anterior aspect of the wrist, in the depression of the distal wrist crease, between the tendons of palmaris longus and flexor carpi radialis), toward the thenar eminence. Primary Needles: Hwato brand (0.25 × 40 mm, Suzhou, China). Primary Patch: Spunlace non-woven hollow patch (with cotton) (5 × 5 cm, ring diameter 2.3 cm, cotton diameter 1.5 cm, Yingrui Pharmaceuticals).
Interventions
The patient is instructed to sit with both hands fully exposed. The practitioner applies the non-woven hollow patch over the skin. Using a 0.3 × 40 mm sterile filiform needle, the practitioner pierces the hollow patch and inserts the needle obliquely downward at a 30°-45° angle to the skin, reaching a depth of 10-15 mm at the heel pain point. An even reinforcing and reducing manipulation (Ping Bu Ping Xie) is applied with small-amplitude, uniform lifting, thrusting, and twirling. Needle insertion stops upon the arrival of Deqi (sensation of soreness, numbness, distension, or pain). The patient is instructed to move, rotate, and stomp the affected heel for 1-2 minutes. After stomping, manipulation ceases; once the numbness in the foot subsides, the patient may stand or walk slowly to assess pain relief. During the procedure, the patient should concentrate on the heel pain, and the operator will periodically monitor for any discomfort. Needles are retained for approximately 15 minutes, a
The patient is positioned supine with the affected lower limb completely relaxed. 1. Kneading and pressing techniques are applied to the affected area using the thumb, with intensity tailored to patient tolerance; focus is placed on localized cord-like structures or fibrous nodules for 5-10 min per session. 2. Horizontal Stretching: With the patient supine and the lower limb extended, the practitioner stabilizes the heel with one hand and pushes the forefoot with the base of the other palm, maximally dorsiflexing the ankle until tension is felt in the Achilles tendon and triceps surae. This stretch is performed 5-10 times for 30 seconds each. 3. Straight-Leg Raise Stretching: The practitioner elevates the affected limb while maintaining knee extension. With the left hand on the heel and the right hand gripping the forefoot, the practitioner leans backward to dorsiflex the ankle until gastrocnemius tension is felt. 4. Ankle Rotation: Building upon step (3), the right han
Preparation is identical to the acupuncture group. The filiform needle is placed against the skin at a 30°-45° angle through the hollow patch but does not penetrate the skin. A secondary patch is applied to secure the needle flat against the skin surface. No needle manipulation is performed. The patient is instructed to sit quietly without movement to prevent inadvertent skin penetration. Needles are retained for 15 minutes. Conducted every other day, with ten sessions constituting one therapeutic course.
Eligibility Criteria
You may qualify if:
- Meeting the aforementioned Western medicine diagnostic criteria for heel pain.
- Aged 40-70 years with a disease duration of less than two months and no prior relevant treatments.
- Voluntary provision of informed consent and willingness to receive the corresponding treatments.
- Presence of calcaneal spurs on X-ray radiography is permitted.
You may not qualify if:
- Presence of gout, trauma, osteomyelitis, or purulent inflammation in the affected area.
- Concomitant history of heel trauma with localized redness, swelling, heat, and inflammatory reactions.
- Chronic conditions that may confound treatment efficacy or outcome interpretation (e.g., cardiovascular disease, diabetic neuropathy, fibromyalgia, rheumatoid arthritis, dementia, epilepsy, or other disqualifying conditions).
- Radicular pain accompanied by lower extremity muscle weakness, sensory loss, diminished reflexes, progressive neurological deficits, or severe neurological symptoms.
- Contraindications to acupuncture (e.g., hemorrhagic diseases, coagulopathy, history of anticoagulant therapy, severe diabetes with infection risk, severe cardiovascular disease).
- History of adverse reactions to acupuncture or alcohol allergies.
- Currently pregnant or planning to conceive.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
Tianjin, China
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Attending Physician
Study Record Dates
First Submitted
May 13, 2026
First Posted
May 26, 2026
Study Start (Estimated)
September 1, 2026
Primary Completion (Estimated)
October 30, 2027
Study Completion (Estimated)
October 30, 2027
Last Updated
May 26, 2026
Record last verified: 2026-05
Data Sharing
- IPD Sharing
- Will not share